pad

Various FDA Meetings, Events, Advocacy

pad
padSentinel Network for Adverse Event Reporting
pad
March 2007 FDA meeting
pad
Ann Fonfa's comments on Sentinel Network
Maryann Napoli's comments on FDA Issues
pad
padFDA 6/8/99 meeting summary
pad
Dietary Supplements
pad
CNN Article 4/12/01
Dietary Supplement Health & Educ Act of 1994
Testimony 6/8/99
pad
pad
padIn vitro diagnostic multivariate index assays -  FDA
pad
Posted February 2007

Advocate Helen Schiff, NYC
pad
pad
padRecommendations on FDA & Drug Safety
pad
Arch Intern Med, 2006
pad
pad
pad
padTestimony of Helen Schiff, Advocate on Abraxane
pad
FDA ODAC Hearing, 9/06/06
pad
pad
padFDA 6/7/99 Time to Disease Progression as Standard?
pad
Amazing discussion: Time To Progression
pad
Ann's Testimony
Epirubicin and FDA Panel
pad
pad
padFDA -Discussion: Drug Approval & Survival
pad
Exerpts from FDA summary www.fda.gov
pad
Reuters Health Coverage of this FDA Meeting
Accelerated Approval-Statement of Maryann Napoli
pad
padFDA Advisors Independence Challenged
pad
USA Today reports 54% have interest in drug/topic being evaluated 9/00
pad
Proposals for Public Disclosure of Advisory Panel Members
FDA Scientists Pressured to Exclude, Alter Findings
pad
pad
padFDA : Compassionate Use of Drugs
pad
Ann's testimony via letter, 2001
pad
pad
padFDA: Patient Use of Non-Approved Oncology Drugs &Biologics
pad
December 14, 2000 Discussion & Patient/Pharmaceutical Testimony
pad
Ann Fonfa's Testimony
Melissa Yazman Testimony
Chelsea Kidd Testimony
pad
pad
padFDA and Consumer Advertising
pad
August 2001
pad
pad
padFDA Sued for Refusing Labels on Antioxidants/Cancer
pad
July, 2001 Reuters Health
pad
pad
pad
padAnn's Comments on Drug User Fee Act
pad
December 2001
pad
FDA Okays Speedier Medication Reviews
FDA Rule Changes: Benefits/Dangers
pad
padAnn's Comments on New Bisphosphonates
pad
January 2002
pad
pad
pad
padFDA/Industry Guidelines for Disclosure
pad
Boston Globe, 3/21/02
pad
Industry Influence on Federal Advisory Committees
Letter to Dr. Lester Crawford, FDA Acting Commissioner
pad
padDutch & Pharma Ads/Mktg
pad
Press Release Health Action Int'l 6/19/02
pad
pad
pad
padEffort to Prohibit Scientists w/Direct Conflicts on Panels
pad
Letter in Support of Senator Durbin, Representative Hinchey June 8, 2005
pad
pad
padExpanded Access to Investigational Drugs
pad
FDA Comment period until March 14, 200
pad
pad
pad
padLilla Romeo, Pt Advocate Quoted on Limits to Anemia Drugs
pad
New York Times, May 9, 2007
pad
pad
padBCPT1:Tamoxifen hearings 1998
pad
Perspective and summary from Sharon Batt, a Canadian activist
pad
Ann Fonfa's Testimony to the FDA 9/2/98
Washington Post Coverage, 9/98
pad

Remember we are NOT Doctors and have NO medical training.

This site is like an Encylopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.